Harvest Health & Recreation Inc. (CSE: HARV, OTCQX: HRVSF), (“Harvest”), a vertically integrated cannabis company and multi-state operator in the U.S., today announced the results of its annual and special meeting of shareholders (the “Harvest Shareholders”) held on September 11, 2020 (the “Meeting”).
The Harvest Shareholders voted in favor of the following agenda items:
- A special resolution authorizing Harvest to amend and restate its Articles, which includes (a) the adoption of an advance notice policy, (b) the removal of certain restrictions regarding the conversion of Multiple Voting Shares to Subordinate Voting Shares, (c) the ability of the directors to remove any director that is deemed to be an “Unsuitable Person”, and (d) certain among other corporate maintenance matters, as more particularly described in the proxy materials sent to the Harvest Shareholders;
- fixing the number of directors for the ensuing year at six and electing Mark Neal Barnard, Steve White, Elroy Sailor, Eula Adams, Ana Dutra, and Scott Atkison as directors of Harvest; and
- appointing Haynie & Company as the auditors of Harvest for the ensuing year and authorizing the directors of Harvest to fix their remuneration.
Full details are contained in the Report of Voting Results for the Meeting which has been filed on SEDAR at www.sedar.com.
About Harvest Health & Recreation Inc.
Headquartered in Tempe, Arizona, Harvest Health & Recreation Inc. is a vertically integrated cannabis company and multi-state operator. Since 2011, Harvest has been committed to expanding its retail and wholesale presence throughout the U.S., acquiring, manufacturing, and selling cannabis products for patients and consumers in addition to providing services to retail dispensaries. Through organic license wins, service agreements, and targeted acquisitions, Harvest has assembled an operational footprint spanning multiple states in the U.S. Harvest’s mission is to improve lives through the goodness of cannabis. We hope you’ll join us on our journey: https://harvesthoc.com
View original content to download multimedia:http://www.prnewswire.com/news-releases/harvest-health–recreation-inc-announces-results-of-annual-shareholder-meeting-301128539.html
SOURCE Harvest Health & Recreation Inc.
View original content to download multimedia: http://www.newswire.ca/en/releases/archive/September2020/11/c4243.html
Investor Contact: Christine Hersey, Director of Investor Relations, +1 (424) 202-0210, firstname.lastname@example.org, www.harvesthoc.comCopyright CNW Group 2020
News Provided by Canada Newswire via QuoteMedia
Aion Therapeutic Inc. (CSE: AION) (” Aion Therapeutic ” or the ” Company “) today announced that it has retained KCSA Strategic Communications (” KCSA “), a leading New York City -based communications firm.
Trulieve Cannabis Corp. (CSE: TRUL) (OTCQX: TCNNF) (“Trulieve” or “the Company”), today announced the closing of its previously announced marketed public offering of 5,000,000 subordinate voting shares in the United States and Canada (the “Offering”) at a public offering price of C$50.00 per share ( $39.63 per share after giving effect to the conversion rate published by Bloomberg at 4:30pm ET on April 7, 2021 to convert Canadian dollars to U.S. dollars). In connection with the closing of the Offering, the underwriters exercised in full their option to purchase an additional 750,000 subordinate voting shares. As a result, the gross proceeds from the Offering, before deducting underwriting discounts and commissions and offering expenses payable by Trulieve, were C$287.5 million (or $227.9 million after giving effect to the conversion rate denoted above).
The Offering was conducted through a syndicate of underwriters led by Canaccord Genuity, as sole book-running manager, and included Cormark Securities Inc., as co-lead manager, as well as ATB Capital Markets Inc., Echelon Wealth Partners Inc., Eight Capital and PI Financial Corp. All of the shares in the Offering were sold by Trulieve. Trulieve intends to use the net proceeds from the Offering primarily to fund Trulieve’s business development and for general working capital purposes.
Ayurcann Holdings Corp. ( CSE: AYUR ) (the “ Company ” or “ Ayurcann ”), is pleased to announce that the Company intends to complete a non-brokered private placement (the “Financing” ) of up to 2,645,503 units (the “Units” ) at a price of $0.189 per Unit. Each Unit will consist of one common share ( “Common Share” ) of the Company and one-half of a common share purchase warrant ( “Warrant” ), with each whole Warrant entitling the holder to acquire one additional Common Share at an exercise price of $0.38 per Common Share for a period of 36 months from the closing date ( “Closing Date” ) of the Financing, for gross proceeds of up to $500,000 .
The Company will have an option, prior to the closing date, to upsize the offering with the sale of an additional 25% of Units, accounting to aggregate proceeds of up to $625,000.
Lobe invites individual and institutional investors as well as advisors and analysts to attend its real-time, interactive presentation at the Emerging Growth Conference
Nextleaf Solutions Receives Amendment to Standard Processing Licence to Allow for Direct to Province Sales
Nextleaf Solutions Ltd. (CSE: OILS) (OTCQB: OILFF) (FSE: L0MA) (“Nextleaf”, “OILS”, or the “Company”), the world’s most innovative cannabis processor, is pleased to announce that its wholly-owned subsidiary, Nextleaf Labs Ltd. (“Nextleaf Labs”), has received an amendment to its existing Standard Cannabis Processing Licence from Health Canada (the “Amendment” or the “Amended Licence”) that authorizes the sale of cannabis extracts, edibles, and topical products, directly to provincially-authorized distributors and retailers across Canada.